dinoprost and Birth-Weight

Increased cortisol release in parturient cows may either represent a stress response or is part of the endocrine changes that initiate calving. Acute stress elicits an increase in heart rate and decrease in heart rate variability (HRV). Therefore, we analyzed cortisol concentration, heart rate and HRV variables standard deviation of beat-to-beat interval (SDRR) and root mean square of successive beat-to-beat intervals (RMSSD) in dairy cows allowed to calve spontaneously (SPON, n = 6) or with PGF2α-induced preterm parturition (PG, n = 6). We hypothesized that calving is a stressor, but induced parturition is less stressful than term calving. Saliva collection for cortisol analysis and electrocardiogram recordings for heart rate and HRV analysis were performed from 32 hours before to 18.3 ± 0.7 hours after delivery. Cortisol concentration increased in SPON and PG cows, peaked 15 minutes after delivery (P < 0.001) but was higher in SPON versus PG cows (P < 0.001) during and within 2 hours after calving. Heart rate peaked during the expulsive phase of labor and was higher in SPON than in PG cows (time × group P < 0.01). The standard deviation of beat-to-beat interval and RMSSD peaked at the end of the expulsive phase of labor (P < 0.001), indicating high vagal activity. Standard deviation of beat-to-beat interval (P < 0.01) and RMSSD (P < 0.05) were higher in SPON versus PG cows. Based on physiological stress parameters, calving is perceived as stressful but expulsion of the calf is associated with a transiently increased vagal tone which may enhance uterine contractility.

Topics: Adrenal Glands; Animals; Birth Weight; Cattle; Dairying; Dinoprost; Female; Heart Rate; Homeostasis; Hydrocortisone; Labor, Induced; Parturition; Pregnancy; Premature Birth; Saliva; Stress, Physiological; Sympathetic Nervous System

The study investigated, for cycling sheep, synchronizing protocols simultaneously to the standard "P" protocol using progestogens priming with intravaginal devices and gonadotropin. In November 2014, 90 adult Menz ewes were assigned to either the "P" protocol, "PGF" treatment where oestrus and ovulation were synchronized using two injections of prostaglandin 11 days apart or a "GnRH" treatment where the ewes had their oestrus and ovulation synchronized with GnRH (day 0)-prostaglandin (day 6)-GnRH (day 9) sequence. The ewes were naturally mated at the induced oestrus and the following 36 days. Plasma progesterone revealed that 92% of the ewes were ovulating before synchronization and all, except one, ovulated in response to the applied treatments. All "P" ewes exhibited oestrus during the 96-hr period after the end of the treatments in comparison with only 79.3% and 73.3% for "PGF" and "GnRH" ewes, respectively (p < .05). Onset and duration of oestrus were affected by the hormonal treatment (p < .05); "GnRH" ewes showed oestrus earliest and had the shortest oestrous duration. Lambing rate from mating at the induced oestrus was lower for "P" than for "PGF" ewes (55.6% and 79.3%, respectively; p < .05). The same trait was also lower for "P" than for "PGF" and "GnRH" ewes (70.4%, 89.7% and 86.7%, respectively; p < .05) following the 36-day mating period. Prostaglandin and GnRH analogue-based protocols are promising alternatives for both controlled natural mating and fixed insemination of Menz sheep after the rainy season when most animals are spontaneously cycling.

Topics: Administration, Intravaginal; Animals; Birth Weight; Dinoprost; Estrus Synchronization; Female; Flurogestone Acetate; Gonadotropin-Releasing Hormone; Litter Size; Ovulation; Pregnancy; Reproduction; Sheep

Oxidative stress is suggested as a potential mechanism in impaired foetal growth, smaller birth size and thus subsequently adult chronic diseases. We have investigated associations between oxidative stress in pregnancy and birth anthropometry (weight, height, head and chest circumferences). In the MINIMat-trial (Maternal and Infant Nutrition Interventions, Matlab) in rural Bangladesh, free 8-iso-prostaglandin F(2α) (lipid peroxidation) was analysed in pregnancy week 14 and 30 and 8-Hydroxy-2 -Deoxyguanosine (DNA oxidation) in week 19. We found that higher levels of lipid peroxidation in early pregnancy were associated with larger infant size (birth length and chest circumference). In late pregnancy, no clear pattern of associations was found. Increasing level of DNA oxidation was associated with lower birth length in girls but no other associations were found. In conclusion, a higher level of lipid peroxidation in early (but not late) pregnancy was associated with a favourable larger birth size suggesting that timing of lipid peroxidation is of importance.

Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Anthropometry; Bangladesh; Biomarkers; Birth Weight; Cohort Studies; Deoxyguanosine; Dietary Supplements; Dinoprost; DNA Damage; Female; Gestational Age; Humans; Infant, Newborn; Lipid Peroxidation; Male; Oxidative Stress; Pregnancy; Sampling Studies; Young Adult

In adults, RRR-alpha-tocopheryl acetate (natural vitamin E) has approximately twice the biological activity of all-rac-alpha-tocopherol (synthetic vitamin E). Similar studies have not been done in term infants.. We evaluated the vitamin E and antioxidant status of term infants fed formulas differing in the amount and form of vitamin E acetate.. A controlled, blinded, multisite study was completed with 77 term infants randomly assigned to 1 of 3 different infant-formula groups. The HIGHNAT-E formula (n = 26) contained 20 IU RRR-alpha-tocopheryl acetate/L (14.5 mg/L), the LOWNAT-E formula (n = 25) contained 10 IU RRR-alpha-tocopheryl acetate/L (7.3 mg/L), and the SYN-E formula (n = 26) contained 13.5 IU synthetic all-rac-alpha-tocopheryl acetate/L (13.5 mg/L). A human milk-fed group (n = 29) served as a reference.. Although the LOWNAT-E formula contained only one-half the concentration of alpha-tocopherol that the SYN-E formula did (7.3 compared with 13.5 mg/L), the infants fed the LOWNAT-E formula had plasma alpha-tocopherol concentrations that were not significantly different from those of the infants fed the SYN-E formula. However, alpha-tocopherol intakes in the study population, when expressed as mg 2R-tocopherol isomers consumed/d, correlated with plasma alpha-tocopherol (r = 0.20, P = 0.02) and the ratio of plasma alpha-tocopherol to lipids (r = 0.19, P = 0.03). There were no significant differences in antioxidant status between the 3 groups, but the LOWNAT-E group showed a trend toward lower plasma isoprostanes.. This study supports the new definition for vitamin E given in the 2000 Dietary Reference Intakes and suggests that infants discriminate between RRR-alpha-tocopheryl acetate and all-rac-alpha-tocopheryl acetate. All 3 infant formulas supported adequate vitaminE status.

Topics: alpha-Tocopherol; Antioxidants; Birth Weight; Dinoprost; Female; gamma-Tocopherol; Gestational Age; Humans; Infant; Infant Food; Male; Nutritional Status; Oxidation-Reduction; Stereoisomerism; Tocopherols

To clarify the safety of elective induction of labor at 39 weeks of gestation.. Prospective randomized study.. Uncomplicated nulliparas (N = 194) were randomly assigned at 36 weeks of gestation. Labor was electively induced in 63 women at 39 weeks of gestation in the active management group (I group, N = 98). Spontaneous labor onset was expected with semi-weekly nonstress test (NST) and amniotic fluid index (AFI) by 42 weeks of gestation in the expectant group (E group, N = 96). Perinatal events were compared between the 2 groups.. A significantly higher incidence of meconium-stained amnios (19.4% vs 3.2%) and fetal resuscitation (16.7% vs 4.8%) was found in the E group than in the I group. Also, although a significantly higher incidence of epidural analgesia was noted in the I group (89%) than in the E group (54%) (labor onset > or = 39 weeks, N = 72), the duration of the 1st stage was shorter in I group and the duration of the 2nd stage was not significantly different. No other significant difference was noted between the 2 groups in terms of the rate of C-section, blood loss, incidence of pathological FHR, birth weight, Apgar score, umbilical arterial pH, or admission to NICU.. Active management of labor at 39 weeks could be made as safely as expectant management with modified biophysical profile monitoring.

Topics: Adult; Amniotic Fluid; Analgesia, Epidural; Apgar Score; Birth Weight; Dinoprost; Dinoprostone; Female; Heart Rate, Fetal; Humans; Infant, Newborn; Labor, Induced; Laminaria; Meconium; Oxytocin; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Prospective Studies

The effect of an intraumbilical prostaglandin (PG) F2 alpha injection on the third stage of normal labor was studied in 54 normal, laboring women at term. Either 1 mg of PGF2 alpha diluted to 20 mL in normal saline (27 women) or 20 mL of normal saline alone (27 women) was injected into the umbilical vein immediately after delivery using a randomized, double-blind protocol. The mean (+/- SD) duration of the third stage was 7.31 +/- 6.37 minutes in the PGF2 alpha patients and 8.94 +/- 7.10 in the normal saline patients. Intraumbilical PGF2 alpha did not influence the third stage of normal labor.

Topics: Adult; Birth Weight; Body Height; Body Weight; Dinoprost; Double-Blind Method; Female; Humans; Injections, Intravenous; Labor Stage, Third; Mothers; Parity; Pregnancy; Sex Ratio; Time Factors; Umbilical Veins

Two experiments were performed to evaluate the use of an intravaginal device (IVD) impregnated with medroxyprogesterone acetate (MPA) to avoid early parturition and synchronize farrowing in sows. In both experiments with IVDs, the gestation length, stillbirth rate, birth weight, colostrum yield, lactational litter performance, and subsequent reproductive performance of sows were assessed. In Experiment 1 (Exp. 1; n = 91), sows were assigned to four treatments to evaluate the minimum required MPA dose: without IVD (CONT; control), 400 mg (MPA400), 600 mg (MPA600), and 800 mg (MPA800) of MPA in the IVD. The IVD was inserted on day 110 of gestation and removed on day 115. No sows farrowed during IVD treatment. Gestation length was increased in treatments with MPA (116.4 days) compared to the control (CONT; 114.9 days; P < 0.01), without effects on piglet birth weight (P = 0.98). A lower percentage of deaths around the farrow (P = 0.02) was observed in the CONT (1.8%) compared to MPA treatments (6.8%). The dose of 400 mg of MPA, validated in Exp. 1, was used in Experiment 2 (Exp. 2; n = 84) to evaluate the performance of sows and piglets in a sow farrowing synchronization protocol. Sows were treated with MPA from days 110-114 of gestation with or without 0.168 mg of cloprostenol sodium (PGF2α), for luteolysis induction, at IVD removal. Thus, four treatments were considered: CONT - without MPA or luteolysis induction (no interventions); PGF2α - luteolysis induction on day 114 of gestation without MPA; MPA114 - MPA treatment till 114 days of gestation without luteolysis induction; MPA114 + PGF2α - MPA treatment and luteolysis induction on day 114 of gestation. The gestation length in treatments with IVDs was longer (P < 0.01) than CONT without a difference for PGF2α treatment (P = 0.46). No impact of IVD use on piglet birth weight (P = 0.67) and deaths around the farrow (P = 0.50) were observed. The colostrum yield (P = 0.65), immunocrit (P = 0.72), piglet performance during lactation (P = 0.81), and weaning-to-estrus interval (P = 0.21) were similar among treatments. In conclusion, the use of IVDs impregnated with 400 mg of MPA between days 110 and 114 of gestation prevented early parturition with no implications for piglet survival at birth, colostrum yield, or litter performance.

Topics: Animals; Birth Weight; Dinoprost; Female; Luteolysis; Medroxyprogesterone Acetate; Parturition; Pregnancy; Swine

Perturbations in normal fetal growth during pregnancy are associated with poor child and adult health outcomes. Inflammation and oxidative stress are recognized as important mechanisms in preeclampsia and preterm birth but have been examined less in relation to fetal growth. We hypothesized that maternal inflammation and oxidative stress in pregnancy would be associated with reduced fetal growth and sought to identify windows of vulnerability.. In a secondary analysis of 482 women from the LIFECODES birth cohort study, we measured inflammation (C-reactive protein [CRP] and the cytokines IL-1β, IL-6, IL-10, and TNF-α) and oxidative stress (8-isoprostane and 8-hydroxydeoxyguanosine [8-OHdG]) biomarkers in plasma and urine, respectively, at four time points during pregnancy. We examined associations between repeated measures of each marker and ultrasound (head and abdominal circumference, femur length, and a summary measure of estimated fetal weight) as well as delivery (birthweight) metrics of growth.. In adjusted repeated-measures models, an interquartile range (IQR) increase in CRP was associated with a 0.12 standard deviation decrease in fetal weight z-score (95% confidence interval, CI, -0.21, -0.02), which corresponds to approximately 50 g at 40-week gestation. The association was greatest in magnitude (ie, most negative) with CRP measured later in pregnancy. Oxidative stress markers were not associated with fetal weight, although both were inversely associated with head circumference and femur length.. Inflammation and oxidative stress markers measured later in pregnancy were associated with reduced fetal growth as measured by repeated ultrasound scans.

Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Biomarkers; Birth Weight; Cytokines; Deoxyguanosine; Dinoprost; Female; Fetal Development; Humans; Infant, Newborn; Inflammation; Male; Oxidative Stress; Pregnancy; Ultrasonography, Prenatal; Young Adult

Lifetime productivity and longevity are greater in beef cows that give birth early in their first calving season. The ability of heifers to conceive early in the breeding season is traditionally thought to be a function of pubertal status; however, recent evidence suggests that antral follicle count is positively associated with calving day in pubertal beef heifers. Additionally, there is evidence to suggest that the total number of ovarian follicles may alter response to hormonal synchronization protocols. The objectives of this study were to confirm the beneficial influence of antral follicle count on calving day in beef heifers and to determine whether response to PGF2α is associated with differences in antral follicle counts. A 2 × 2 factorial experiment was designed to investigate the interaction between calving period (early vs. late) and PGF2α (control vs. PGF) on calving day and antral follicle count in yearling beef heifers (n = 95). As intended, calving day was less in the early calving period compared to the late calving period (P < 0.01). There were no differences in calving day in response to treatment with PGF2α (P > 0.05). There was a significant interaction between calving period and PGF2α on age at first calving (P < 0.01), such that heifers treated with PGF2α that gave birth early were younger than heifers treated with saline that gave birth early. Calf weaning weights were greater in the early calving group than in the late calving group (P < 0.01). Heifers that gave birth in the early calving group possessed more antral follicles at prebreeding ultrasonographic examination than heifers that gave birth in the late calving group (P = 0.05). These findings confirm that antral follicle counts are associated with calving day in pubertal beef heifers. The use of antral follicle counts as a prebreeding phenotype provides additional utility to reproductive tract scoring for commercial production because of its association with calving day. As a prebreeding ovarian phenotype, antral follicle counts may hold additional applicability for organic beef producers looking to reduce the length of their calving season without increasing the total number of replacement heifers retained.

Topics: Animals; Birth Weight; Body Weight; Breeding; Cattle; Dinoprost; Female; Male; Ovarian Follicle; Parturition; Pregnancy; Sexual Maturation; Ultrasonography; Weaning

Data concerning the effects of prenatal exposures to nonylphenol (NP) and oxidative stress on neonatal birth outcomes from human studies are limited. A total of 146 pregnant women were studied (1) to investigate the association between prenatal NP exposure and maternal oxidative/nitrative stress biomarkers of DNA damage (8-hydroxy-2'-deoxyguanosine (8-OHdG), 8-nitroguanine (8-NO2Gua)) and lipid peroxidation (8-iso-prostaglandin F2α (8-isoPF2α), 4-hydroxy-2-nonenal-mercapturic acid (HNE-MA)) and (2) to explore the associations among oxidative stress biomarkers, NP exposure, and neonatal birth outcomes, including gestational age, birth weight, length, Ponderal index, and head and chest circumferences. NP significantly increased the 8-OHdG and 8-NO2Gua levels. All infants born to mothers with urinary 8-OHdG levels above the median exhibited a significantly shorter gestational duration (Badjusted = -4.72 days; 95% CI: -8.08 to -1.36 days). No clear association was found between NP levels and birth outcomes. Prenatal 8-OHdG levels might be a novel biomarker for monitoring fetal health related to NP exposure.

Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Adult; Biomarkers; Birth Weight; Cohort Studies; Deoxyguanosine; Dinoprost; DNA Damage; Environmental Pollutants; Female; Gestational Age; Guanine; Humans; Infant, Newborn; Lipid Peroxidation; Male; Maternal Exposure; Oxidative Stress; Phenols; Pregnancy; Pregnancy Outcome; Taiwan

Cord blood 8-isoprostane (8-IP) is a marker of lipid peroxidation in the peripartum period. The independent association with degree of prematurity is not well-described.. To identify patterns of lipid peroxidation among early, moderate and late preterm infants, and to understand how cord blood 8-IP varies with gestational age (GA) and related covariates.. Mother-infant pairs from 237 preterm births were studied as part of a longitudinal birth cohort study. GA subgroups were defined as extremely (≤28w), moderately (29-33w), and late (34-36w) preterm. Cord blood 8-IP was measured using EIA. Elevated 8-IP (4th quartile) was the primary outcome for multivariate logistic regression models, which were adjusted for maternal age/race, multiple gestation and infant gender, as well as other relevant covariates.. Elevated 8-IP was associated with extremely preterm birth (OR=4.31; 95% CI=1.90, 9.76), and was inversely associated with increasing GA (OR=0.88; 95% CI=0.80, 0.97). Elevated 8-IP was also associated with decreasing birth weight (BW), clinical chorioamnionitis, fetal inflammatory response of the placenta (FIR), and signs of perinatal depression. The GA on 8-IP association appeared to be modified by several maternal disease and fetal-infant factors. Lastly, the indirect associations between log-transformed 8-IP, GA and BW appeared to be most prominent for GA<30w and for BW<2000g.. Lipid peroxidation in preterm birth, and the relative influence of accompanying peripartum factors, varies according to degree of prematurity. These findings have important implications for the developmental regulation of antioxidant defense and its impact on neonatal outcomes.

Topics: Adult; Birth Weight; Dinoprost; Female; Fetal Blood; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Lipid Peroxidation; Male; Pregnancy; Premature Birth; Sex Factors

The etiology of preeclampsia (PE) is unknown and the only treatment is removal of the fetus and placenta. The critical changes of this state include the increase of vascular resistance and hypoperfusion in the uteroplacental microcirculation that predispose to hypoxia and ischemia and, therefore, increased oxidative stress through 8-isoprostane, which is characterized by damage to the placenta and endothelium. We undertook this study to compare oxidative stress in pregnant women with PE.. A case-control, cross-sectional and comparative study was undertaken. Pregnant women between 28 and 38 weeks of gestation with and without PE were recruited. Venous blood samples were taken for determination of 8-isoprostane. Obstetrical variables were measured and 8-isoprostane by radioimmunoassay. SPSS v.11 for Windows was used for descriptive statistics. Mean ± standard deviation, correlation and χ(2) were used for comparison between groups.. We studied 45 patients: 20 with PE (44.6%) and 25 without PE (55.4%). The average for 8-isoprostane in preeclamptic patients was 699.2 ± 38.6 pg/dl and without PE was 113.9 ± 52.4 pg/dL (p <0.01), gestational age 32.1 ± 2.6 and 35.1 ± 1.8 weeks, birth weight 1880 ± 238 g and 2787 ± 312 g, respectively. Apgar at birth was similar in both groups.. We found statistical differences in the 8-isoprostane levels in both groups. There was no correlation in perinatal results in both groups according to 8-isoprostane levels. These results could be the basis for the use of antioxidants in the management of PE to counteract tissue damage.

Topics: Adult; Apgar Score; Biomarkers; Birth Weight; Case-Control Studies; Dinoprost; Female; Humans; Infant, Newborn; Oxidative Stress; Pre-Eclampsia; Pregnancy; Statistics, Nonparametric; Young Adult

Our aim was to evaluate the effect of BW and obesity on oxidative stress and IR in prepubertal SGA and LGA children compared with appropriate-for-gestational-age (AGA) children.. We performed a cross-sectional study comparing oxidative stress and IR in 103 children categorized into 6 groups according to BW (26 SGA, 15 AGA, and 16 LGA normal-weight children) and obesity (15 SGA, 15 AGA, and 16 LGA obese children). Indexes of IR (HOMA-IR, G/I) and the marker of oxidative stress (urinary isoprostanes) were evaluated.. Homeostasis Model Assessment was higher in both normal-weight SGA and LGA children than in normal-weight AGA children (all P

Topics: Anthropometry; Birth Weight; Child; Child, Preschool; Cross-Sectional Studies; Dinoprost; Female; Fetal Macrosomia; Humans; Infant; Infant, Newborn; Infant, Small for Gestational Age; Insulin Resistance; Isoprostanes; Longitudinal Studies; Male; Obesity; Oxidative Stress; Pregnancy; Reference Values; Regression Analysis; Risk Factors

The objectives of this study were to determine whether oxidative stress early in pregnancy influenced pregnancy outcome. A combination of assays were used for exogenous and endogenous anti-oxidants together with two well accepted biomarkers for oxidative stress, the urinary excretion of 8-iso-PGF(2alpha) (a biomarker marker for lipid oxidation, n=508) and 8-oxo-7,8 dihydro-2 deoxyguanosine (8-OHdG, a biomarker for DNA oxidation, n=487). The two biomarkers tracked different pregnancy outcomes. Isoprostanes were associated with an increased risk of pre-eclampsia and a decreased proportion of female births. In contrast, 8-OHdG tracked lower infant birthweight and shortened gestation duration. Birth defects were associated with low levels of 8-OHdG.

Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Antioxidants; Biomarkers; Birth Weight; Congenital Abnormalities; Deoxyguanosine; Dinoprost; DNA Damage; Female; Gestational Age; Humans; Infant, Newborn; Lipid Peroxidation; Male; Middle Aged; Oxidants; Oxidative Stress; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Prospective Studies; Young Adult

Oxygen toxicity is thought to contribute to the development of bronchopulmonary dysplasia (BPD). Oxidant injury leads to formation of F(2)-isoprostanes (F(2)-IsoP). We hypothesized that urinary excretion of the stable metabolite of F(2)-IsoP, 8-iso-PGF(2alpha), would be higher in infants who develop BPD than those who did not.. Forty infants <30-weeks gestational age (GA) were enrolled, 24 infants with BPD and 16 without BPD. Urine specimens were collected weekly and stored at -80 degrees C until analyzed. Urinary 8-iso-PGF(2alpha) was measured by gas chromatography/mass spectrometry (GC-MS) and normalized to creatinine excretion.. GA and birth weight (BW) were lower in infants who developed BPD than those who did not. Urinary 8-iso-PGF(2alpha) levels in the first or third weeks of age were not significantly different between the two groups.. Urinary excretion of 8-iso-PGF(2alpha) in early postnatal life in preterm infants is not correlated with the development of BPD.

Topics: Biomarkers; Birth Weight; Bronchopulmonary Dysplasia; Dinoprost; F2-Isoprostanes; Female; Gas Chromatography-Mass Spectrometry; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Male; Predictive Value of Tests; Prognosis; Risk Factors

It is hypothesised that oxidative stress is a key mechanism of ethanol neurobehavioural teratogenicity, resulting in altered endogenous antioxidant status and increased membrane lipid peroxidation in the hippocampus of chronic prenatal ethanol exposure (CPEE) offspring. To test this hypothesis, timed pregnant guinea-pigs (term, approximately gestational day (GD) 68) received chronic daily oral administration of (i) 4 g ethanol kg(-1) maternal bodyweight, (ii) isocaloric sucrose with pair feeding, or (iii) water. At GD 65 (term fetus) and postnatal day (PD) 0 (neonate), individual offspring were killed, the brain was excised and the hippocampi were dissected. Glutathione (GSH) concentration was measured in the cytosolic and mitochondrial fractions of hippocampal homogenate. The occurrence of lipid peroxidation was determined by measuring the concentration of 8-iso-prostaglandin F2+/- (8-iso-PGF2+/-). There was CPEE-induced decreased brain weight and hippocampal weight at GD 65 and PD 0, decreased mitochondrial GSH concentration in the hippocampus at PD 0, with no change in mitochondrial GSH concentration at GD 65 or cytosolic GSH concentration at GD 65 or PD 0, and no change in mitochondrial or whole-homogenate 8-iso-PGF2+/- concentration in the hippocampus at GD 65 or PD 0. The data demonstrate that CPEE produces selective mitochondrial dysfunction in the hippocampus of the neonatal guinea-pig, involving GSH depletion.

Topics: Animals; Animals, Newborn; Birth Weight; Cytosol; Dinoprost; Ethanol; Female; Fetal Weight; Gestational Age; Glutathione; Guinea Pigs; Hippocampus; Maternal-Fetal Exchange; Mitochondria; Organ Size; Pregnancy

Topics: Animals; Animals, Newborn; Birth Weight; Dexamethasone; Dinoprost; Female; Litter Size; Swine

This experiment tested the hypothesis that opioid antagonists could influence the timing of the onset and progress of parturition in the pig. Primiparous pigs (gilts) received a jugular catheter on Days 104 to 106 of pregnancy. At 1400 h on Day 112 the gilts received 10 mg PGF2alpha, i.m. to induce parturition. At 1000 h on Day 113 (i.e., 20 h later) gilts received either saline (n=6), 1 mg/kg, i.v. naltrexone (n=4) or 1 mg/kg, i.v. naloxone (n=5). Blood samples were taken daily from Days 108 to 116. On Day 113, blood samples were taken hourly from 0500 to 0900 h and then every 30 min until 2400 h, or until the birth of the last piglet (BLP) (whichever was sooner) and assayed for progesterone, oxytocin (OT), cortisol and PRL. Additional blood samples for OT and cortisol assay were taken every minute from 0930 to 1100 h on Day 113 and for 30 min during parturition. Naloxone, but not naltrexone, delayed the onset of parturition relative to saline controls (by 14 h 21 min; P<0.05). Duration of parturition and rate of births were not significantly affected by treatment. Mean plasma OT increased in the 4 h following naloxone but not saline treatment, during which time OT plasma pulse amplitude was reduced in naloxone and naltrexone-treated animals relative to saline treated controls. The PRL secretion rose following treatment in saline treated animals, consistent with approaching parturition, but failed to rise in opioid antagonist treated animals. Progesterone concentrations remained elevated in naloxone-treated animals for longer than in the other groups. These data suggest that a rapid change in overall effect of parenteral administration of naloxone to parturient pigs occurs from delaying its onset when administered as in these experiments, to facilitating its progress when given during parturition (earlier experiments). The delay of onset of parturition may be mediated by interference with hypothalamic control of OT or PRL release.

Topics: Animals; Birth Weight; Dinoprost; Female; Hydrocortisone; Labor, Obstetric; Naloxone; Narcotic Antagonists; Oxytocin; Pregnancy; Progesterone; Prolactin; Swine; Time Factors

This study was designed to examine the effects of intrauterine endotoxin (lipopolysaccharide) on rat pregnancy.. Pregnant Sprague-Dawley rats (N = 26) were implanted with uterine catheters on day 15 or 16 of a 22-day gestation. Animals were randomly assigned to receive either lipopolysaccharide (25 or 50 microg) or sodium chloride solution (1 mL) on day 17 and then were either sacrificed on day 19 or observed until delivery. Placentas were harvested at the time of death, homogenates were prepared, and prostaglandin F(2)(alpha) metabolite levels were determined by means of radioimmunoassay. Data were analyzed by analysis of variance, Student-Newman-Keuls, and Mann-Whitney tests.. Lipopolysaccharide-treated groups (25 and 50 microg) displayed a shorter interval to delivery (mean +/- SE, 82 +/- 13 and 63 +/- 8 hours, respectively) than control animals (117 +/- 3 hours). Pups of lipopolysaccharide-treated (25 and 50 microg) female animals had lower live birth weights (4.92 +/- 0.01 and 5.12 +/- 0. 24 g, respectively) compared with control animals (6.04 +/- 0.07 g). Placental homogenates from lipopolysaccharide-treated female animals contained higher levels of prostaglandin F(2)(alpha) metabolite (1567 +/- 64 and 1475 +/- 59 pg/mL) than those from sodium chloride solution-infused control animals (804 +/- 68 pg/mL).. Bacterial products induce the preterm delivery of low-birth-weight pups in rats, possibly by increasing local prostaglandin biosynthesis.

Topics: Animals; Birth Weight; Catheterization; Delivery, Obstetric; Dinoprost; Dose-Response Relationship, Drug; Endotoxins; Female; Fetal Weight; Lipopolysaccharides; Obstetric Labor, Premature; Organ Size; Placenta; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Uterus

The objective of this study was to determine the effect of feeding strategies in cows that allowed BW loss followed by BW gain on the efficiency of feed utilization for calf production. The first treatment (H-H-H) was designed to maintain body condition score of mature cows at 5.5 from the second trimester until the subsequent breeding season. The second treatment (L-H-H) was designed such that cows lost body condition during the second trimester and regained it during the third trimester and were equal in weight and body condition scores at parturition to cows assigned to the H-H-H treatment. The third treatment (L-L-H) was designed such that cows lost body condition during the second trimester and gained body condition after 28 d of lactation so that they would be equal to the other two treatments at breeding. Forty-eight cows were assigned to each treatment. Total DMI over the entire study did not differ between the H-H-H and L-H-H treatments (P = 0.23), but intake on both were higher than the L-L-H treatment (P < 0.001). Calf birth weight of the H-H-H treatment did not differ (P = 0.43) from those of L-H-H, but both groups were greater than those of the L-L-H (P < or = 0.002) treatment. At 28 d of age, H-H-H (P = 0.008) and L-H-H (P = 0.007) calves weighed more than the L-L-H calves, but at 58 d of age there was no difference in calf BW among the treatments (P = 0.81). The percentage of cows that were diagnosed pregnant at weaning with their next calf did not differ (P = 0.71) among treatments. We interpret the results of this study to suggest that weight cycling in mature beef cows may be a viable management tool for decreasing food costs.

Topics: Animals; Birth Weight; Body Weight; Cattle; Dinoprost; Energy Intake; Female; Food Deprivation; Pregnancy; Pregnancy, Animal; Random Allocation; Time Factors

The aim of this study was to evaluate the difference in birth weight and gestation length between Japanese Black calves obtained from transfer of bovine embryos produced in vitro (IVP) and those developed in vivo (IVD). An additional objective was to clarify the sire effect on birth weight and gestation length and to examine the birth rate of heavier calves. Two Japanese Black bulls breed at our experimental station were used as a semen source for production of IVP and IVD embryos. Thirty-eight Japanese Black heifers and cows of various genetic backgrounds were used as embryo donors for IVD embryos. Ovaries for IVP embryos were collected at random at a local slaughterhouse from Japanese Black cattle of various genetic backgrounds. IVP embryos were produced using co-culturing with cumulus cells in 5% CS+TCM 199. Both the IVD and IVP embryos were transferred non-surgically to Holstein recipients on day 7+/-1 of estrous cycle. In this study, the birth weights and gestation lengths of half-sib single calves for bull A and B were analyzed. The numbers of single calves born by transfer of IVP and IVD embryos for bull A and B were 133 and 121, 243 and 465, respectively. The birth weight of the IVP calves was significantly higher (P<0.01) than that of the IVD (bull A: 31.0+/-0.4 kg versus 27.2+/-0.4 kg and bull B: 29.9+/-0.6 kg versus 26.6+/-0.2 kg). Gestation length of the IVP calves for bull A was significantly longer (P<0.01) than that of the IVD (291.9+/-0.9 days versus 283.6+/-0.5 days). However, for bull B, there were no differences in gestation length between the IVP and IVD calves (285.9+/-0.7 days versus 286.2+/-0.3 days). These results clearly indicated that IVP calves had heavier birth weights than IVD calves but that the average gestation length of IVP calves was not always longer than that of IVD calves. Furthermore, the birth rate of heavier calves and the incidence of stillbirth and perinatal mortality up to 48 h post partum in IVP calves (bull A: 11.3%, bull B: 7.8%) were greater (P<0.05) than those in IVD calves from both bulls (bull A: 4.1%, bull B: 3.7%).

Topics: Animals; Animals, Newborn; Birth Rate; Birth Weight; Cattle; Cryopreservation; Dinoprost; Embryo Transfer; Female; Fertilization in Vitro; Fetal Death; Follicle Stimulating Hormone; Gestational Age; Male; Oocytes; Pregnancy

At birth, the physiological role of prostaglandins in bitches is unclear. Bitches were treated before parturition with either saline, the prostaglandin analogue, sodium cloprostenol, or the prostaglandin synthetase inhibitor, flunixin meglumine. The animals were examined regularly to determine the onset of parturition and a series of blood samples were taken to define the hormonal profiles before, during and after birth. Animals treated with cloprostenol whelped earlier than did controls. In addition, the prostaglandin F2 alpha metabolite surge and decrease in plasma progesterone concentration and rectal temperature were earlier than in controls. Flunixin meglumine disrupted the normal 13,14-dihydro-15-keto prostaglandin F2 alpha profile but did not abolish prostaglandin synthesis completely or delay the onset of labour in treated animals. This study confirms that prostaglandins induce luteolysis and the onset of labour in the bitch. However, the partial inhibition of prostaglandin synthesis does not prevent parturition.

Topics: Analysis of Variance; Animals; Area Under Curve; Birth Weight; Body Temperature; Clonixin; Cloprostenol; Cyclooxygenase Inhibitors; Dinoprost; Dogs; Drinking; Female; Labor Onset; Luteolysis; Pregnancy; Progesterone; Prostaglandins, Synthetic

Effects of lipid infusion into postpartum (PP) beef heifers on plasma concentrations of linoleic acid and prostaglandin (PG) F(2alpha) metabolite (PGFM), days to first estrus, and subsequent pregnancy rate were examined. Treatments (n = 5 per group) of 1 L intralipid (20% soybean oil; IL), 1 L 50% dextrose (DEXT; isocaloric to IL), 0.5 L intralipid (0.5 IL), and 1 L physiological saline (SAL) were infused i.v. over 4 h on each of Days 7 through 11 PP. Capacity of the uterus to produce PG was evaluated after i.v. injection of 150 IU of oxytocin (OT) to IL- and DEXT-treated heifers Day 12 PP. Change in plasma concentrations of PGFM from 0 to 4 h was greater for IL-treated heifers than for heifers given other treatments on Day 7 (P = 0.04) and on Day 11 (P = 0.01), but not on Day 9 (P>0.10). Plasma linoleic acid on Day 11 and OT-induced release of PGFM on Day 12 were greater in IL-treated heifers compared with DEXT-treated heifers (P<0.06 and P = 0.01, respectively). There were no significant differences among treatments for mean days to first estrus or pregnancy rate. Infusion of lipid increased systemic concentrations of linoleic acid and increased the capacity of PP heifers to produce uterine PGF(2alpha) as indicated by plasma PGFM concentration after OT injection.

Topics: Animals; Behavior, Animal; Birth Weight; Body Weight; Cattle; Dinoprost; Eating; Estrus; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Female; Fertility; Linoleic Acid; Ovary; Postpartum Period; Pregnancy; Prostaglandins

The prostaglandin-like compound 8-iso-prostaglandin F(2alpha) represents an index of oxidative stress and has the ability to induce endothelial derangement, platelet activation, and vasoconstriction. In women with preeclampsia the decidual spiral arteries contain lipid deposits (acute atherosis). Analogously to the elevated level of 8-iso-prostaglandin F(2alpha) demonstrated in atherosclerotic lesions, we hypothesized that 8-iso-prostaglandin F(2alpha) level would be elevated in preeclamptic decidua basalis tissues.. Decidua basalis tissues were obtained by vacuum aspiration and placental tissues were obtained by excision at cesarean delivery from 16 preeclamptic and 15 normal pregnancies. Total and free 8-iso-prostaglandin F(2alpha) concentrations were quantified with an enzyme immunoassay technique after lipid extraction and separation.. The content of free 8-iso-prostaglandin F(2alpha) in preeclamptic decidual tissues was found to be significantly elevated with respect to that in control tissues. The content of total 8-iso-prostaglandin F(2alpha) did not differ significantly between the groups in either placenta or decidua basalis.. We propose that free 8-iso-prostaglandin F(2alpha) released from the decidua basalis in preeclampsia may mediate maternal vascular dysfunction and platelet activation.

Topics: Adult; Birth Weight; Blood Pressure; Body Mass Index; Decidua; Dinoprost; F2-Isoprostanes; Female; Humans; Infant, Newborn; Parity; Placenta; Pre-Eclampsia; Pregnancy; Proteinuria; Time Factors

Dexamethasone treatment induces premature birth in tammar wallabies. Treatment was administered at one of three times between 1200 h on Day 24 and 0930 on Day 25, and birth occurred 22.8 +/- 0.5 h later, significantly earlier than the time of birth for controls, which was 47.7 +/- 2.3 h after treatment. The neonates from treated females were significantly lighter than control neonates (360 +/- 9 vs. 413 +/- 5 mg), and 60% of these died within 12 h of birth, suggesting that premature birth can lead to neonatal mortality. None of the control neonates died. The patterns of secretion of prolactin, prostaglandin F2 alpha-metabolite (PGFM), and progesterone of control and treated animals around the time of birth were similar. A transient pulse of PGFM was coincident with birth while prolactin levels in plasma increased before, and progesterone concentrations fell steeply immediately after, parturition in both groups of animals. The only difference between control and treated animals was in the timing of the hormonal events, which, along with birth, was significantly advanced by the treatment. We conclude that cortisol may play a role in triggering parturition in this marsupial species.

Topics: Animals; Birth Weight; Dexamethasone; Dinoprost; Female; Glucocorticoids; Hydrocortisone; Labor, Obstetric; Macropodidae; Obstetric Labor, Premature; Pregnancy; Progesterone; Prolactin; Prostaglandins

We investigated differences in maternal plasma and trophoblast prostaglandin metabolism associated with preterm births. Tissue prostaglandins (PGs) E2 and F2 alpha and the stable plasma PGF2 alpha metabolite, 13,14-dihydro-15-keto-PGF2 alpha, were measured in preterm (< 37 weeks) and term (< or = 37 weeks) births. Amnion PGE2 in preterm (106.1 +/- 15.7 ng/g wet weight tissue; x +/- SEM; n = 37) was lower than in term (176.6 +/- 22.7 ng/g wet weight; x +/- SEM; n = 34, P < 0.02). Placenta PGE2 was lower in preterm (34.7 +/- 19.7 ng/g wet weight; x +/- SEM) than in term (103.3 +/- 28.0 ng/g wet weight; x +/- SEM, P < 0.04). Preterm PGF2 alpha was consistently lower in the amnion (106.8 +/- 17.5 ng/g wet weight) and placenta (102.5 +/- 8.7 ng/g wet weight) than in term amnion (188.2 +/- 24.8 ng/g wet weight; P < 0.01) and placenta (128.9 +/- 7.8 ng/g wet weight; P < 0.03). Chorionic PGE2 and plasma PGF2 alpha metabolite followed this trend but did not reach significance. These findings suggest qualitative and quantitative differences in maternal and trophoblast eicosanoid metabolism between term and preterm parturition.

Topics: Adult; Age Factors; Amnion; Birth Weight; Body Weight; Chorion; Dinoprost; Dinoprostone; Embryo, Mammalian; Female; Gestational Age; Humans; Infant, Newborn; Labor, Obstetric; Obstetric Labor, Premature; Placenta; Pregnancy; Prostaglandins

This study has used an in vitro perfusion method to investigate the mechanism by which CRH causes vasodilatation in the human fetal-placental circulation. In normal term placentas, vasodilatory responses to human CRH (24-7000 pmol/L) were examined during submaximal vasoconstriction (100-120 mm Hg) of the fetal-placental vasculature induced by prostaglandin F2 alpha (0.7-2 mumol/L), KCl (50-100 mmol/L), or the thromboxane A2 mimetic, U46619 (0.05-0.5 mumol/L). Infusion of CRH caused a concentration-dependent vasodilatation that was similar in the presence of each constrictor agent (P > 0.05). The CRH antagonist, alpha-helical CRH-(9-41) (200 pmol/L), and a polyclonal CRH antiserum significantly inhibited CRH-induced vasodilatation during constriction with prostaglandin F2 alpha (P < 0.05). Vasodilatory responses to CRH were attenuated by the nitric oxide synthase inhibitor, N omega-nitro-L-arginine (100 mumol/L; P < 0.05), and the guanylate cyclase inhibitor, LY 83583 (1 mumol/L; P < 0.05), but not by the cyclooxygenase inhibitor, indomethacin (3 mumol/L; P > 0.05). In placentas of women with increased fetal vascular resistance, as demonstrated by Doppler ultrasound waveforms in vivo, CRH-induced vasodilatation was significantly reduced (P < 0.05). These results indicate that in the human fetal-placental circulation, CRH causes a vasodilatory response via a nitric oxide-/cGMP-dependent pathway. CRH may play a role in the control of vascular resistance to blood flow in the normal human placenta, and there may be a deficiency in the CRH signaling pathway of placentas with increased fetal vascular resistance.

Topics: Adult; Birth Weight; Corticotropin-Releasing Hormone; Cyclic GMP; Diabetes, Gestational; Dinoprost; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Fetus; Humans; In Vitro Techniques; Infant, Newborn; Maternal-Fetal Exchange; Muscle, Smooth, Vascular; Nitric Oxide; Placenta; Potassium Chloride; Pregnancy; Pregnancy Complications; Reference Values; Regression Analysis; Signal Transduction; Vascular Resistance; Vasoconstriction; Vasodilation

Effects of breed of service sire and cow on birth weight and prepartum and postpartum endocrine function were studied in multiparous Brahman (n = 20) and Angus (n = 20) cows bred to Brahman or Angus bulls. Before calving, blood samples were collected on d 34 to 28, 27 to 21, 20 to 14, and 13 to 7, and after calving, samples were collected from d 0 to 7. Progesterone (P4), estrogen (E2), and 13,14-dihydro-15-keto-prostaglandin F2 alpha (PGFM) were quantified with RIA. Calves born to Brahman were smaller (P < .05) than calves born to Angus cows. Prepartum concentrations of P4 were greater in Angus cows and decreased more rapidly near parturition than in Brahman cows (breed of dam x period; P < .03). Cows bearing bull calves had greater concentrations of P4 on d 20 to 14 before calving than cows bearing heifer calves (sex of calf x period; P < .04). Prepartum E2 was influenced (P < .05) by the breed of dam x breed of sire x period interaction. The ratio of P4:E2 tended to decrease more in Angus than in Brahman cows near parturition (breed of dam x period; P < .09). Postpartum PGFM tended to be influenced (P < .08) by breed of dam x breed of sire; from d 3 to 5, Brahman cows bred to Angus bulls tended (P < .08) to have greater PGFM than Brahman cows bred to Brahman bulls or than Angus cows bred to Brahman or Angus bulls.2+ f1p4

Topics: Animals; Birth Weight; Breeding; Cattle; Dinoprost; Estrogens; Female; Male; Postpartum Period; Pregnancy; Pregnancy, Animal; Progesterone; Radioimmunoassay; Sex Characteristics

To determine the concentrations of the metabolites of prostaglandin E2 (PGEM) and of prostaglandin F2 alpha (PGFM) prior to the onset of labour and during spontaneous labour, and to correlate the changes in concentrations of these metabolites with labour outcome.. Longitudinal study throughout labour.. Labour ward of a large maternity unit.. Seven primigravid and 11 parous women in the late third trimester with no signs of labour, and 17 primigravid and 11 parous women in spontaneous labour.. Six of the primigravid women required augmentation with oxytocin because of dysfunctional labour.. Before labour, parous women had significantly higher concentrations of both PGEM (P < 0.007) and PGFM (P < 0.006) compared with primigravid women. During labour, PGFM concentrations were significantly higher in both primigravid (P < 0.0002) and parous (P < 0.0001) women compared with the concentrations of these metabolites in women not in labour; the same was true for PGEM in primigravid (P < 0.003) but not in parous (P = 0.1) women. There was a small but significant increase (P < 0.02) in PGEM as labour progressed in both the normal groups. Amniotomy was associated with a significant increase in PGFM in primigravid and parous women (P < 0.002 and P < 0.009, respectively). The concentration of PGFM one hour following amniotomy correlated inversely with the amniotomy to delivery interval in both the normal primigravid (r = -0.624; P = 0.04) and the parous (r = 0.745; P = 0.021) groups. Women with dysfunctional labour showed no significant rise in PGEM or PGFM. Their PGFM concentrations were significantly lower than those seen in normal labour (P < 0.05). The concentration of PGFM in cord blood was significantly higher (P < 0.0001) in the parous women who laboured than in women delivered by elective caesarean section. There was no difference in the corresponding concentrations of PGEM (P = 0.9).. These data show that spontaneous labour is associated with increased concentrations of prostaglandin metabolites in the maternal plasma, and are consistent with PGF2 alpha being an important stimulator of uterine contractility, with a relative deficiency of PGF2 alpha being associated with dysfunctional labour.

Topics: Adult; Birth Weight; Dinoprost; Dinoprostone; Female; Gestational Age; Humans; Labor, Obstetric; Longitudinal Studies; Maternal Age; Obstetric Labor Complications; Oxytocin; Parity; Pregnancy; Time Factors

In the present study, plasma oxytocin and prostaglandin F2 alpha metabolite (PGFM) concentrations were measured in 46 patients admitted for preterm labour. Gestational age ranged from 20-34 weeks. Samples were collected 12 hours before and after initiation of tocolysis. Patients with a premature rupture of the membranes and/or intra-amniotic infection were excluded in this study. There was a significant difference in the oxytocin (p = 0.05) and PGFM levels (p = 0.007, after 12 hours: p = 0.004) between a control group without preterm labour and women with preterm labour. No differences were seen between the successfully treated (delivery more than 5 days after start of tocolysis) and the failure group. There was no significantly different increase or decrease in PGFM and Oxytocin plasma levels between treatment failures and successfully treated patients.

Topics: Birth Weight; Dinoprost; Female; Gestational Age; Hexoprenaline; Humans; Infant, Newborn; Infusions, Intravenous; Obstetric Labor, Premature; Oxytocin; Pregnancy; Tocolysis; Uterine Contraction

Purebred Ayrshire females were assigned to two groups based on the breed of fetus carried during gestation. In group 1, Limousin embryos were transferred nonsurgically into Ayrshire recipients (10 heifers and 1 cow), and in group 2, 11 Ayrshire heifers and 1 cow were inseminated artificially to Ayrshire bulls. Blood samples were collected daily from d 265 of gestation until d 15 postpartum from 5 heifers of each group. Milk yield was recorded on alternate weeks during the first 20 wk postpartum. Calf birth weight was higher (44.2 vs. 35.4 kg) and gestation was longer (297.4 vs. 280.2) in Ayrshire dams bearing Limousin fetuses than in those bearing Ayrshire fetuses. Daily milk production for the first 20 wk was lower (18.1 vs. 20.8 kg) in Ayrshire dams bearing Limousin fetuses than in those bearing Ayrshire fetuses. Prepartum decrease in progesterone concentrations and increase in estrone concentrations were faster in Ayrshire heifers bearing Limousin fetuses than in those bearing Ayrshire fetuses. Profiles of peripartum concentrations of bovine placental lactogen differed between Ayrshire carrying different families of Limousin fetuses but were similar in those carrying families of Ayrshire fetuses. The concentrations of 15-keto-13,14-dihydroprostaglandin F2 alpha were lower during the postpartum period in heifers than gave birth to Limousin calves than in those that had Ayrshire calves. In conclusion, the breed of fetus influences physiological and endocrine responses of the dam, which might have some effect on milk production of the dam.

Topics: Animals; Birth Weight; Breeding; Cattle; Dinoprost; Embryo Transfer; Estrone; Female; Insemination, Artificial; Lactation; Male; Placental Lactogen; Postpartum Period; Pregnancy; Pregnancy, Animal; Progesterone

To elucidate the role of endogenous prostaglandin F2 alpha in spontaneous and induced labor, plasma concentrations of 13, 14-dihydro-15-keto-prostaglandin F2 alpha (PGFM) were determined before the onset of labor, at onset of labor, during active labor, at the crowning of the fetal head, and 1 and 2 hours after delivery. Patients in spontaneous labor and labor induced by amniotomy, oxytocin, and prostaglandin E2 were studied. The levels of plasma PGFM in patients who entered spontaneous labor fell 2 to 3 weeks before delivery, whereas those in the induced labor group did not change until the time of induction. Although the levels of PGFM rose gradually with the progress of labor in all cases, the levels in the spontaneous labor were significantly lower in each stage than in the corresponding stage of induced labor. These results suggest that endogenous prostaglandin F2 alpha (PGF2 alpha) production decreases 2-3 weeks prior to the spontaneous onset of labor and is increased again as labor progresses, that the patterns of PGF2 alpha production are similar to each other during spontaneous labor and labor induced by various methods. Therefore, it is felt that endogenous PGF2 alpha may participate in the progress of all kinds of labor.

Topics: Adult; Amnion; Apgar Score; Birth Weight; Dinoprost; Dinoprostone; Female; Humans; Labor, Induced; Labor, Obstetric; Oxytocin; Pregnancy; Prostaglandins E; Prostaglandins F

Prostaglandin PGF2 alpha seems to act satisfactorily as a birth inducing agent in red deer (Cervus elaphus). The progress of actual delivery and lactation in the experiments of induced parturition corresponds with observations from natural conditions. The pattern of response time to the birth inducing agent agrees with experience from domesticated species, being longest in females with the least developed fetuses. Complications such as those reported from practice with induced parturition in domestic species were not experienced in the three experiments on red deer. Applications of prostaglandin PGF2 alpha prior to approximately 18-20 days preterm probably reduce chances for the offspring to survive. This seemingly being due to ontogenetical immaturity in the fetus, and deficient hormonal development in the mother, necessary for normal lactogenesis.

Topics: Animals; Birth Weight; Deer; Dinoprost; Electrocardiography; Female; Heart; Heart Rate; Labor, Obstetric; Pregnancy; Prostaglandins F

For the assessment of the influence of the Defense Medical College planned delivery method upon neonates, the measurement of the blood constituents of the umbilical cord was conducted. Statistically speaking, no marked differences were seen between the neonates delivered by the Defense Medical College Method and neonates delivered naturally. The blood constituents investigated were: Blood cells, activity of various enzymes, other blood constituents and electrolytes.

Topics: Adult; Alanine Transaminase; Apgar Score; Aspartate Aminotransferases; Birth Weight; Dinoprost; Dinoprostone; Electrolytes; Female; Fetal Blood; Humans; Infant, Newborn; Japan; Labor, Induced; Labor, Obstetric; Lipids; Pregnancy; Prostaglandins E; Prostaglandins F; Schools, Medical

In a historical cohort study the outcome of the first birth after a legal 2nd trimester two-stage abortion induced with saline or prostaglandin F2 alpha was evaluated for 142 nulliparous and 65 parous women. The birth-outcome was compared with that for 180 parity-matched control women and for all women in Sweden 1975. No statistically significant differences were disclosed with regard to means of infants' birthweight and length of gestation, or to occurrence of low birthweight (LBW) infants and preterm deliveries. The nulliparous women with a previously induced abortion tended, however, to have more LBW-infants than did the other nulliparae . More LBW-infants were born to the 29 nulliparae with a previous abortion induced with prostaglandin than to the 113 nulliparae having abortions induced with saline (p = 0.11); otherwise no noteworthy differences were found in the birth-outcome for the 39 women with a previous abortion induced by prostaglandin, compared with the 168 having abortions induced by saline.

Topics: Abortion, Induced; Adult; Birth Weight; Dinoprost; Female; Follow-Up Studies; Gestational Age; Humans; Parity; Pregnancy; Pregnancy Trimester, Second; Prostaglandins F; Saline Solution, Hypertonic

In order to determine if prostaglandin values correlate with gestational age, birth weight, postnatal age, or respiratory distress syndrome (RDS), we determined plasma prostaglandin F2 alpha (PGF2 alpha) and prostaglandin E2 (PGE2) by specific radioimmunoassay in 34 samples from 27 preterm infants. Neither prostaglandin correlated with gestational age or with birth weight. PGF2 alpha decreased (p less than 0.3) with postnatal age. Values for PGF2 alpha and PGE2 in each sample varied together (p less than .01) but only PGF2 alpha increased (p less than .09) in infants with RDS. The highest PGF2 alpha values occurred in infants with severe RDS, including four infants with patent ductus arteriosus (PDA). In contrast, plasma PGE2 was not elevated in infants with RDS or PDA.

Topics: Age Factors; Birth Weight; Dinoprost; Dinoprostone; Ductus Arteriosus, Patent; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Prostaglandins E; Prostaglandins F; Respiratory Distress Syndrome, Newborn